#JITC Research: Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab https://t.co/y5DxbQ5f50 https://t.co/KU40gGya1M
19,075 followers
4,590 followers
RT @sitcancer: #JITC Research: Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved o…
438 followers
RT @sitcancer: #JITC Research: Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved o…
19,075 followers
#JITC Research: Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab https://t.co/y5DxbQ5f50 https://t.co/2RcgvYYidB